MERYX
Meryx is a biotechnology company that develops orally bio-available cancer drugs targeting receptor tyrosine kinases. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancers such as leukemia, lung cancer, and melanoma. It offers potent inhibitors of MerTK, such as MRX-2843, a clinical drug candidate; and MRX-6313, a backup candidate that inhibit growth and initiate anti-tumor immunity in a range of hematologic and solid malignancies. Meryx was founded in 2013 and is based in Chapel Hill, North Carolina.
MERYX
Industry:
Biotechnology Medical Medical Device
Founded:
2013-01-01
Address:
Chapel Hill, North Carolina, United States
Country:
United States
Website Url:
http://www.meryxpharma.com
Total Employee:
1+
Status:
Active
Contact:
(919) 985-7821
Total Funding:
5.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS DreamHost Hosting Dreamhost DNS Meteor
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.meryxpharma.com
- Host name: apache2-cabo.iad1-shared-b7-24.dreamhost.com
- IP address: 67.205.5.96
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
More informations about "Meryx"
Meryx - Crunchbase Company Profile & Funding
Meryx is a biotechnology company that develops orally bio-available cancer drugs targeting receptor tyrosine kinases. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancers such as …See details»
Meryx, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Meryx, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, Disease Domain:Hemic and Lymphatic Diseases, Immune System Diseases, Neoplasms, …See details»
Meryx Company Profile 2024: Valuation, Investors, Acquisition
Information on acquisition, funding, cap tables, investors, and executives for Meryx.See details»
Meryx - Ownership and Business Overview | Mergr
Dec 7, 2021 · Meryx is a clinical stage immuno-oncology company focused on advancing small molecule, orally bioavailable inhibitors of Mer Receptor Tyrosine Kinase (RTK) that inhibit …See details»
Meryx Inc. - VentureRadar
Website: http://www.meryxpharma.com. Meryx is developing small-molecule, orally-bioavailable RTK inhibitors that inhibit growth and initiate anti-tumor immunity in hematologic and solid …See details»
Meryx Inc. Company Profile | Chapel Hill, NC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Meryx Inc. of Chapel Hill, NC. Get the latest business insights from Dun & Bradstreet.See details»
Meryx - Products, Competitors, Financials, Employees, …
Meryx is a clinical-stage immuno-oncology company focused on advancing small molecule, orally bioavailable inhibitors of Mer Receptor Tyrosine Kinase (RTK) that inhibit growth and initiate …See details»
Meryx Inc. - CAGE.report
Nov 13, 2017 · https://www.meryxpharma.com. Contact Person: Stephen Frye County Code (3 digit): 135 Congressional District: 04 Metropolitan Statistical Area: 6640 CAGE Code: 71PC6 …See details»
Meryx Inc. Asset Profile | Preqin
Established in 2013 and based in North Carolina, US, Meryx Inc. operates as a biotechnology company that develops orally bioavailable drugs for cancer diseases such as leukemia, lung …See details»
Meryx’s Competitors, Revenue, Number of Employees, Funding
Meryx’s Profile, Revenue and Employees. Meryx is a North Carolina-based biotechnology company that develops and commercializes small molecule therapies for the treatment of …See details»
Meryx Pharma - Company Profile - Tracxn
Sep 20, 2024 · Meryx is developing orally bioavailable cancer drugs targeting receptor tyrosine kinases with the potential to both inhibit tumor growth and initiate anti-tumor immunity in a …See details»
Meryx Company Profile - Office Locations, Competitors, Revenue …
Meryx has 1 employees at their 1 location. See insights on Meryx including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Xcovery Acquires Majority Controlling Stake in Meryx ... - BioSpace
Dec 7, 2021 · Meryx, Inc. is a clinical stage immuno-oncology company focused on advancing small molecule, orally bioavailable inhibitors of Mer Receptor Tyrosine Kinase (RTK) that …See details»
Xcovery Acquires Majority Controlling Stake in Meryx …
Dec 7, 2021 · PALM BEACH GARDENS, Fla.-- ( BUSINESS WIRE )-- Xcovery Holdings, Inc., an oncology focused bio-pharmaceutical company, is proud to announce the acquisition of a …See details»
Xcovery Acquires Majority Controlling Stake in Meryx …
Dec 8, 2021 · Xcovery Holdings, Inc., an oncology focused bio-pharmaceutical company, is proud to announce the acquisition of a majority and controlling stake in Meryx Inc., a clinical stage …See details»
Xcovery Acquires Majority Controlling Stake in Meryx …
Dec 7, 2021 · PALM BEACH GARDENS, Fla.–(BUSINESS WIRE)–Xcovery Holdings, Inc., an oncology focused bio-pharmaceutical company, is proud to announce the acquisition of a …See details»
About Us - Emery Pharma
Emery Pharma is a full-service contract research organization (CRO) that supports the end-to-end development of small molecule drugs, biologics, biosimilars, gene therapy, botanicals, and more.See details»
Xcovery Acquires Majority Controlling Stake in Meryx …
Dec 7, 2021 · PALM BEACH GARDENS, Fla.-- (BUSINESS WIRE)-- Xcovery Holdings, Inc., an oncology focused bio-pharmaceutical company, is proud to announce the acquisition of a …See details»
Emery Pharma Contract Research Laboratory Organization (CRO)
Emery Pharma is a full-service Contract Research Organization (CRO) that delivers customized solutions with a range of services and leadership expertise to accelerate life science innovations.See details»
Emery Pharma and Marin Biologic Laboratories Announce …
Sep 10, 2024 · Alameda, CA, and Novato, CA – September 10, 2024 – Emery Pharma, a leader in bioanalytical chemistry, mass spectrometry, and CMC services, and Marin Biologic …See details»